Neumora Therapeutics (NMRA) Other Non-Current Assets (2022 - 2026)
Neumora Therapeutics' Other Non-Current Assets came in at $53,000 for Q2 2026, down 82.2% from $298,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Other Non-Current Assets (2022 - 2026) Analysis & Trends
Going back to Q3 2022, Neumora Therapeutics' Other Non-Current Assets data covers 16 quarters.
- Other Non-Current Assets carries a three-year compound annual growth rate of -65.2% (FY2022 to FY2025).
- Going back by year, Other Non-Current Assets was $1.21 million in FY2024 (unchanged), $1.21 million in FY2023 (-4.0%) and $1.26 million in FY2022.
- The five-year range for quarterly Other Non-Current Assets is $53,000 (Q4 2025) to $1.26 million (Q4 2022).
- Year-over-year, Other Non-Current Assets has declined for five consecutive quarters, with an average decline of 54.1% over the last eight quarters.
- Across the past five years, year-over-year decline in Other Non-Current Assets ran from 0.0% in Q1 2025 to 95.6% in Q4 2025.
- Business Quant data shows NMRA's Other Non-Current Assets at $53,000 (Q1 2026), $53,000 (Q4 2025) and $197,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Neumora Therapeutics | 129.65 Mn | 129.65 Mn | - | 53,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53,000.00 |
| Mar 31, 2026 | 53,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 197,000.00 |
| Jun 30, 2025 | 298,000.00 |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.26 Mn |
API Access
Neumora Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();